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BACKGROUND AND PURPOSE 
The spider-venom peptide PcTx1 is the most potent and selective inhibitor of acid-sensing 
ion channel (ASIC) 1a. It has centrally acting analgesic activity and is neuroprotective in 
rodent models of ischemic stroke. Understanding the molecular details of the PcTx1:ASIC1a 
interaction should facilitate development of therapeutically useful ASIC1a modulators. 
Previously we showed that several key pharmacophore residues of PcTx1 reside in a dynamic 
-hairpin loop, conclusions that were confirmed by recent crystal structures of the complex 
formed between PcTx1 and chicken ASIC1 (cASIC1). A large number of peptide:channel 
contacts were observed in these crystal structures but it remains unclear which of these are 
functionally important. 
EXPERIMENTAL APPROACH 
We combined molecular dynamics (MD) simulations of the PcTx1:cASIC1 complex with 
mutagenesis of PcTx1 and rat ASIC1a. 
KEY RESULTS 
Crystal structures of the PcTx1:cASIC1 complex indicate that 15 PcTx1 residues form a total 
57 pairwise intermolecular contacts (<5 Å) with 32 channel residues. MD simulations, 
however, suggest that about half of these interactions do not persist in solution. We found 
that mutation to alanine of only eight of 15 PcTx1 contact residues substantially altered 
ASIC1a inhibition by PcTx1. Our data reveal that many of the peptide-channel interactions 
observed in the PcTx1:cASIC1 crystal structures are not important for PcTx1 inhibition of 
rASIC1a. 
CONCLUSIONS AND IMPLICATIONS 
We identified the atomic interactions that are critical for PcTx1 inhibition of ASIC1a. Our 
data highlight the value of combining structural information, MD and functional experiments 
to obtain detailed insight into the molecular basis of protein:protein interactions. 
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Non-standard abbreviations 
ASIC Acid-sensing ion channel 
HL -Hairpin loop 
cASIC1 Chicken acid-sensing ion channel, isoform 1 
ECD Extracellular domain 
HMQC Heteronuclear multiple quantum coherence 
HSQC Heteronuclear single quantum coherence 
MALDI-TOF  Matrix-assisted laser desorption/ionisation time-of-flight 
MS Mass spectrometry 
MBP Maltose binding protein 
MD Molecular dynamics 
PcTx1 Psalmotoxin-1 (also known as -theraphotoxin-Pc1a) 
rASIC1a Rat acid-sensing ion channel, isoform 1a 
RMSD Root-mean-square deviation 
RP-HPLC Reversed-phase high-performance liquid chromatography 
TEV Tobacco etch virus 
TEVC Two-electrode voltage-clamp 
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Introduction 
Acid sensing ion channels (ASICs) are chordate-specific members of the degenerin/epithelial 
sodium channel family (Kellenberger and Schild, 2002) that are primarily expressed in the 
central and peripheral nervous system. They are gated by protons and are the primary acid 
sensors in mammalian neurons (Gründer and Chen, 2010; Waldmann et al., 1997). ASICs 
have been implicated in inflammatory and neuropathic pain (Deval et al., 2010; Izumi et al., 
2012), psychiatric illnesses (Coryell et al., 2009), seizure termination (Ziemann et al., 2008) 
and ischemic stroke (Xiong et al., 2004), and are therefore considered important therapeutic 
targets (Chu and Xiong, 2013; Dussor, 2015; Li and Xu, 2015; Wemmie et al., 2013). 
 
Six ASIC subunits (ASIC1a/b, ASIC2a/b, ASIC3 and ASIC4) can combine to form homo- or 
heterotrimeric channels. Each subunit contains a large extracellular domain (ECD), two 
transmembrane helices, and short intracellular N- and C-termini. The subunit composition of 
each channel determines its pH sensitivity, kinetics, and pharmacology (Hesselager et al., 
2004; Wemmie et al., 2013). The crystal structure of chicken ASIC1 (cASIC1; orthologue of 
rodent/human ASIC1a) revealed the trimeric architecture of ASICs and highlighted a 
negatively charged surface-accessible cavity, termed the "acidic pocket", at each subunit 
interface (Jasti et al., 2007). The acidic pocket was proposed to be the main proton-sensing 
site on ASICs (Jasti et al., 2007), and disruption of carboxyl-carboxylate interactions in this 
cavity confirmed that this region is central to channel activation (Jasti et al., 2007; 
Ramaswamy et al., 2013). However, proton gating of ASICs appears to be highly complex as 
two independent studies also highlighted a role in proton sensing for residues at the top of 
transmembrane domain 1 in ASIC1a (Paukert et al., 2008) and ASIC2a (Baron et al., 2001).  
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The most selective and potent inhibitor of ASIC1a reported to date is PcTx1, a disulfide-rich 
peptide isolated from spider venom. PcTx1 inhibits homomeric ASIC1a and heteromeric 
ASIC1a/2b channels with IC50 values of 0.9 nM and 3 nM, respectively (Escoubas et al., 
2000; Sherwood et al., 2011), but it does not inhibit other subtypes (Escoubas et al., 2003; 
Escoubas et al., 2000). PcTx1 is a gating modifier that stabilises the desensitised state of 
ASIC1a (Chen et al., 2005). At higher concentrations, PcTx1 potentiates rat and human 
ASIC1b (Chen et al., 2006; Hoagland et al., 2010), and opens cASIC1 (Baconguis and 
Gouaux, 2012; Samways et al., 2009) by stabilising the open state of these subtypes. 
 
PcTx1 is a 40-residue peptide stabilised by a classical inhibitor cystine knot motif, with a 
dynamic -hairpin loop (HL) protruding from the disulfide-rich core (Fig. 1A) (Escoubas et 
al., 2003; Saez et al., 2011). Site-directed mutagenesis combined with in silico docking 
revealed that PcTx1 binds into the acidic pocket of ASIC1a, with residues Trp24, Arg26 and 
Arg27 within the HL being critical for PcTx1 inhibition of the channel (Saez et al., 2011). 
These data supported the results of studies on chimeric ASICs that gave the first indication of 
regions essential for PcTx1 binding (Chen et al., 2006; Salinas et al., 2006). Two recent 
crystal structures of the PcTx1:cASIC1 complex (Baconguis and Gouaux, 2012; Dawson et 
al., 2012) not only confirmed the importance of the interaction between the HL and the 
acidic pocket but revealed a more extensive network of contacts than would have been 
predicted from prior functional studies. In both crystal structures, the HL of PcTx1 is deeply 
buried in the acidic pocket, making contact with adjacent channel subunits. Additional 
interactions are made between the thumb domain of one channel subunit and residues in loop 
1 and the C-terminal region of PcTx1 (Fig. 1B). 
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The crystal structure of the PcTx1:cASIC1 complex (PDB 3S3X) reveals an extensive 
network of 57 intermolecular contacts (which we define as pairwise interactions <5 Å) 
involving 32 channel and 15 peptide residues (Dawson et al., 2012). However, it has been 
well documented that only a small subset of "hot spot" residues typically contributes most of 
the binding free energy at protein-protein interfaces, and that the surface accessibility of a 
residue correlates poorly with its energetic contribution to a protein-protein interaction 
(Bogan and Thorn, 1998; Kortemme and Baker, 2002). Thus, we sought to take advantage of 
the PcTx1:cASIC1 crystal structure in order to define the subset of PcTx1 residues that are 
crucial for PcTx1 inhibition of ASIC1a.  
 
In this study, we used molecular dynamics (MD) simulations to predict which PcTx1 residues 
found at the protein-protein interface in the PcTx1:cASIC1 crystal structure are likely to be 
functionally important. We then tested these predictions by performing extensive 
mutagenesis of PcTx1. We also examined the functional consequence of mutating channel 
residues in close proximity to bound PcTx1. We show that only a subset of intermolecular 
contacts observed in the PcTx1:cASIC1 crystal structure are critical for PcTx1 inhibition of 
ASIC1a. Identification of these hot-spot residues provides a solid platform for rational design 
of therapeutically useful PcTx1 mimetics. 
 
Methods 
MD simulations. The PcTx1:cASIC1 crystal structure (PDB 3S3X) (Dawson et al., 2012) 
was used to perform simulations of the extracellular domain (ECD) of cASIC1 with PcTx1 
molecules bound at each of the three subunit interfaces (Fig. 1B). The few missing residues 
in each channel subunit were modelled using the equivalent region from an alternative 
structure of the PcTx1:cASIC1 complex (PDB 4FZ0) (Baconguis and Gouaux, 2012). The 
  
This article is protected by copyright. All rights reserved. 
channel protein was truncated at residues Leu71 and Val427 and the N- and C-termini were 
capped with amide and acetyl groups, respectively, to mimic a continuous backbone 
structure. PropKa (Li et al., 2005) was used to predict the local pKa of all Glu, Asp and His 
residues. Tautomeric states of His residues were chosen based on the most likely hydrogen-
bonding pattern. Disulfide bonds were modelled as in the crystal structure.  
 
All simulations were carried out with GROMACS version 3.3.3 (van der Spoel et al., 2005), 
using the GROMOS54a7 force field (Schmid et al., 2011). The cASIC1 ECD was solvated 
with SPC water (Berendsen et al., 1981) and neutralised with 19 Na
+
 and 1 Cl
–
 ion, which 
corresponds to an overall concentration of 100 mM NaCl. The system was energy minimised, 
followed by a 2-ns simulation with position restraints on all channel and peptide atoms and a 
subsequent 2-ns simulation with position restraints on all channel backbone atoms. 
Simulations (60 ns each) were performed in triplicate using a 2-fs time-step. Constant 
temperature (298 K) was maintained using a Berendsen thermostat (Berendsen et al., 1984) 
with time constant of 0.1 ps. Isotropic pressure coupling with a time constant of 0.5 ps and a 
-5
 bar
–1
 was used to maintain pressure at 1.0 bar. Non-bonded 
interactions were calculated using a twin-range method with a 0.8 nm short-range cut-off in 
which interactions were updated every time step and a long-range cut-off of 1.4 nm in which 
the van der Waals and electrostatic interactions were updated every 10 steps together with the 
pairlist. To correct for the effect of truncating the electrostatic interactions beyond the 1.4 nm 
cut-off, a reaction field correction was applied assuming a dielectric constant of 78. Covalent 
bonds in the protein and peptide were constrained using LINCS.  
 
Analysis of MD trajectories. Trajectories were analysed using GROMACS analysis tools plus 
custom tcl and python scripts. Based on a combination of the root mean square deviation 
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(RMSD) of cASIC1 and PcTx1, the potential energy of the system, and the distance between 
PcTx1 and channel residues as a function of simulation time, the simulations were considered 
to have equilibrated after ~25 ns. Configurations sampled after 30 ns were used for analysis 
(600 frames per simulation). In the first phase of analysis, we identified channel residues with 
any atom within 5 Å of any side-chain atom of PcTx1 contact residues (i.e., Lys6, Trp7, 
Lys8, Trp24, Lys25, Arg26, Arg27, Arg28, Ser29, Phe30, Val32, Val34, Pro35, Thr37, 
Pro38). The fractional occurrence of each of these PcTx1:cASIC1 residue pairs was 
calculated by counting the number of frames for which residues were within 5 Å for non-
bonded interactions and 2.5 Å for hydrogen bonds. Strong hydrogen bonds are typically 
shorter than 2.2 Å (Jeffrey, 1994; Stone, 1996) but favourable interactions can be present up 
to 2.5 Å. Electrostatic and hydrophobic interactions are effective over a longer range than 
hydrogen bonds and can make significant contributions to protein stability and binding 
energies at distances of 5 Å or longer (Israelachvili and Pashley, 1982; Kumar and Nussinov, 
2002; Stone, 1996). We used 5 Å as the cut-off for these interactions to enable direct 
comparison with contacts previously reported for the PcTx1:cASIC1 complex (Dawson et al., 
2012). The fractional occurrence of each residue-pair was averaged over the three peptides in 
the system and over the three trajectories. A non-bonded interaction was deemed to be 
persistent if the fractional occurrence was at least 90%; this value was chosen based on a 
histogram of all fractional occurrences (Supp. Fig. S4). 
 
Production of Recombinant PcTx1 and variants. Recombinant peptides were produced as 
described (Klint et al., 2013; Saez et al., 2011). Briefly, synthetic genes encoding wild-type 
(WT) or mutant PcTx1, preceded by a tobacco etch virus (TEV) protease cleavage site, were 
subcloned into a variant of the pLicC-His6-MBP periplasmic expression vector in which 
target peptides are expressed as fusions to a His6-tagged maltose binding protein (MBP). 
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Fusion proteins were expressed in E. coli BL21(DE3) and isolated from cell lysates using 
Ni-NTA Superflow resin (QIAGEN). The His6-MBP tag was removed from the eluted fusion 
protein by cleavage with TEV protease, then rPcTx1 was purified using reversed-phase 
HPLC (RP-HPLC). rPcTx1 contains a non-native N-terminal Ser residue that facilitates TEV 
cleavage; this recombinant peptide is equipotent with native PcTx1 (Saez et al., 2011). 
 
Purity and integrity of recombinant peptides. Peptide purity was verified using analytical RP-
HPLC and mass spectrometry (MS). Peptides were eluted from a Thermo Aquasil C18 
column (2.1 × 50 mm) connected to a Shimadzu Prominence UPLC system using a linear 
gradient of 10–50% solvent B (90% acetonitrile, 10% H2O, 0.043% TFA) over 30 min, at a 
flow rate of 0.25 ml/min. Matrix-assisted laser desorption ionisation–time-of-flight (MALDI–
TOF) MS was performed using a model 4700 Proteomics Bioanalyser (Applied Biosciences). 
RP-HPLC fractions of pure peptides were mixed [1:1 (v/v)] with α-cyano-4-hydroxy-
cinnamic acid matrix (7.5 mg/ml in 50/50 acetonitrile/H2O, 0.1% TFA) and MALDI–TOF 
mass spectra acquired in reflector positive mode. All masses reported are for monoisotopic 
M+H
+
 ions. The folding of rPcTx1 variants was assessed by comparison of their 2D 
1
H-
15
N 
HSQC or HMQC NMR spectra with that of WT PcTx1 (Saez et al., 2011).  
 
Production of rASIC1a mutants. Point mutations were introduced into an rASIC1a-pRK5 
plasmid by PCR using standard protocols with Platinum Pfx DNA Polymerase (Invitrogen) 
(Qi and Scholthof, 2008). Mutant cDNA constructs were sequenced to verify incorporation of 
the desired mutation (Australian Genome Research Facility, Brisbane, Australia).  
 
Electrophysiology. Peptide activity was assessed using two-electrode voltage-clamp (TEVC) 
electrophysiology on Xenopus laevis oocytes expressing WT or mutant rASIC1a. Oocyte 
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preparation, cRNA/cDNA injections, and electrophysiology were performed as described 
(Saez et al., 2011). We injected 0.25 ng cRNA for WT rASIC1a and 2 ng cDNA for rASIC1a 
mutants. (In control experiments the pH-dependent channel properties of rASIC1a were the 
same regardless of whether we injected cRNA or cDNA.) Currents were elicited by a pH 
drop from 7.45 to 6.0 every 60 s using a microperfusion system to allow rapid solution 
exchange (~1.5 mL/min) at 21–22°C. Serial dilutions of PcTx1 were administered at pH 7.45 
for 55 s between pH stimulations. pH activation curves were determined using a conditioning 
pH of 7.9 for 55 s (± 30 nM PcTx1) before switching to an activating pH of 4.5 to 7.35 for 
5 s. Steady-state desensitisation (SSD) curves were obtained by exposing oocytes to a 
conditioning pH ranging from 7.9 to 6.7 for 115 s (± 30 nM PcTx1), before pH 5.0 
stimulation for 5 s. Currents were normalised to the maximal current evoked in each test 
condition. In all experiments, the ND96 solution contained 0.1% bovine serum albumin 
(BSA) to minimise adsorption of PcTx1 onto tubing. A non-linear fit to the data of a four-
parameter logistic equation ("sigmoidal dose-response") was used to obtain the half-maximal 
response (IC50 or pH50) and Hill coefficient (nH). Statistical analyses comparing differences 
between WT and mutant channels were based on analysis of variance followed by a Dunnett 
post hoc test. Data are mean ± S.E.M. (n = number of oocytes). Oocyte studies complied with 
the Australian code of practice for care and use of animals for scientific purposes and were 
approved by The University of Queensland Animal Ethics Committee (Approval No. 
QBI/059/13/ARC/NHMRC). Oocytes were obtained via recovery surgery performed under 
tricaine methanesulfonate anesthesia. The minimum time between surgeries on the same 
animal was three months. All drug and molecular target nomenclature used in this report 
conforms to BJP's Concise Guide to Pharmacology (Alexander et al., 2013). 
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Results 
MD simulations. The fact that a PcTx1 residue is found in close proximity to cASIC1 in a 
crystal structure of the complex does not necessarily mean that this pairwise interaction helps 
stabilise the complex. However, intermolecular contacts that make energetically important 
contributions to a protein:protein interaction are likely to persist in solution. MD simulations 
are ideally suited for studying the temporal nature of protein-ligand interactions (Durrant and 
McCammon, 2011), and therefore we performed MD simulations of the PcTx1:cASIC1 
complex in solution in order to predict which contacts observed in the crystal structure are 
likely to be persistent and functionally important. Table 1 reports the percentage of time that 
each intermolecular interaction persisted in the simulations and highlights hydrogen bonds 
and non-bonded interactions formed by side chains of PcTx1 residues that are predicted to 
persist in solution. The MD simulations did not reveal any persistent intermolecular contacts 
that were not evident in the PcTx1:cASIC1 crystal structures. 
 
Only 31 of the 57 non-bonded interactions observed in the PcTx1:cASIC1 crystal structure 
(Baconguis and Gouaux, 2012; Dawson et al., 2012) are predicted to persist in solution. No 
close contacts involving PcTx1 residues Lys6 and Lys25, and only one of three contacts 
observed for Ser29, are predicted to persist in solution. The MD simulations predict that more 
than half of the persistent PcTx1 interactions (18 of 31) are formed by just four residues 
(Trp24, Arg26, Arg27, Arg28) in the βHL, consistent with previous functional studies (Saez 
et al., 2011). The simulations also suggest that Trp7 in loop 1 might be functionally important 
as it forms stable contacts with six channel residues. None of ten intermolecular hydrogen 
bonds identified in the PcTx1:cASIC1 crystal structure had consistently high fractional 
occurrences across the three independent simulations (Supp. Fig. S4). 
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The first reported structure of cASIC1 (Jasti et al., 2007) revealed three pairs of proximal 
Asp and Glu residues within the acidic pocket (Asp238–Asp350, Glu239–Asp346 and 
Glu220–Asp408). These carboxyl-carboxylate pairs are key sites for pH-sensing by ASICs 
(Jasti et al., 2007; Ramaswamy et al., 2013). In our MD simulations, Asp238 was found 
within 5 Å of Arg26, Arg28, and Ser29 for most of the simulation time (77%, 98% and 93%, 
respectively). Asp346 and Asp350 were within 5 Å of Arg26 for the entire simulation and 
Asp350 showed persistent contact with Trp24. Finally, Glu220 was within 5 Å of Arg27 for 
99% of the simulation time and the same PcTx1 residue was within 5 Å of Asp408 for 64% 
of the simulation time. In summary, five out of the six putative proton-sensing residues were 
within 5 Å of at least one PcTx1 residue for the vast majority of the simulation time. 
 
Functional importance of N-terminal PcTx1 residues. PcTx1 activity was confirmed using 
TEVC assays on Xenopus oocytes expressing rASIC1a. The measured IC50 of 0.35 ± 0.04 nM 
for WT PcTx1 agrees well with previous studies (Escoubas et al., 2000; Saez et al., 2011). To 
identify PcTx1 residues critical for inhibition of ASIC1a we tested the ability of 13 alanine 
mutants (Fig. 1) and two truncation mutants to modulate the activity of rASIC1a. Fig. 2 
shows concentration-effect curves and Table 2 shows corresponding IC50 (or EC50) values for 
all 15 PcTx1 variants. Natural abundance 2D 
1
H-
15
N HMQC or HSQC spectra acquired of 
each variant confirmed that most mutations did not perturb the structure of PcTx1. 
 
Deletion of the two N-terminal residues (i.e., Glu1 and Asp2; ΔN2) did not alter PcTx1 
potency (Fig. 2A; Table 2), suggesting that the deleted residues are not functionally 
important. This is consistent with the absence of channel contacts observed for these residues 
in the PcTx1:cASIC1 crystal structure. Mutation of Trp7 to Ala had minimal effect on the 
structure of PcTx1 as assessed by NMR (Supp. Fig. S1) but it almost abolished PcTx1 
  
This article is protected by copyright. All rights reserved. 
activity (Fig. 2A, Table 2). This indicates that Trp7 is functionally critical, as might be 
expected from the numerous contacts it makes with residues within helix 4 and 5 of the 
thumb region of cASIC1 in MD simulations. Mutation of Lys6 to Ala caused a 97-fold 
decrease in PcTx1 activity. However, comparison of 2D HSQC spectra of the K6A mutant 
and WT PcTx1 (Supp. Fig. S1) revealed that this mutation causes substantial differences in 
chemical shifts of the backbone and indole ring signals of Trp7, suggesting that the loss of 
activity is likely caused by structural differences within or surrounding Trp7 rather than loss 
of channel interactions with Lys6. Mutation of Lys8 to Ala caused only a minor decrease in 
the inhibitory activity of PcTx1, despite the MD studies predicting a close contact between 
this residue and Glu343 in cASIC1 (Table 1). 
 
Functional importance of residues in the PcTx1 β-hairpin loop. Mutating Glu31 to Ala did 
not significantly affect PcTx1 activity (Fig. 2B, Table 2), consistent with the absence of 
intermolecular contacts for Glu31 in the crystal structure. In contrast, the IC50 for inhibition 
of rASIC1a was increased 14.5-fold for the R28A mutant (Fig. 2B, Table 2). In contrast with 
the PcTx1:cASIC1 structure solved by Dawson et al. (2012) (PDB 3S3X), Arg28 did not 
make close contacts with Glu236 or Glu243 in the MD simulations. Rather, Arg28 was close 
to Phe242, Thr240, and the putative proton-sensing residue Asp238 (see Table 1) as observed 
in the structure reported by Baconguis et al. (2012) (PDB 4FZ0). Regardless of its exact 
mode of binding, Arg28 clearly makes energetically favourable interactions with the channel. 
Surprisingly, the F30A mutant potentiated rather than inhibited rASIC1a (EC50 ~7 nM; 
Fig. 2B, Table 2). In the MD simulations (Table 1) and both crystal structures, Arg26 and 
Phe30 are the only PcTx1 residues within 5 Å of channel residue Lys342. Interestingly, as 
found for F30A in this study, an R26A mutant potentiates rASIC1a (Saez et al., 2011).  
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Mutation of Ser29 to Ala did not significantly alter PcTx1 activity despite the potential for 
this residue to interact with channel residue Asp238 (Table 1). In the PcTx1:cASIC1 crystal 
structure, Val32 contacts only one channel residue (Pro347), yet mutation of Val32 to Ala 
caused an 18-fold decrease in PcTx1 activity. This residue is largely buried at the base of the 
-hairpin. This raised the question as to whether the reduced activity of the V32A mutant 
results from loss of important PcTx1:channel interactions or is due to structural perturbations 
induced by the mutation. The 2D 
1
H-
15
N HSQC spectrum of the V32A mutant reveals that 
while the chemical shifts for most residues are very similar to those in WT PcTx1 (Supp. Fig. 
S2), substantial chemical shift differences were observed for HL residues that are important 
for inhibition of ASIC1a, namely Trp24, Arg26, Arg27, Arg28 and Phe30. We therefore 
conclude that the diminution in activity caused by the V32A mutation results from induced 
structural changes in the HL. 
 
Functional importance of C-terminal PcTx1 residues. Deletion of the three C-terminal 
residues (i.e., Pro38, Lys39, Thr40; 1–37, C3) caused a minor 4-fold reduction in PcTx1 
potency (Fig. 2D; Table 2). Mutation of Pro38 to Ala also resulted in a 4-fold decrease in 
potency (Fig. 2D; Table 2), suggesting that loss of this residue may be entirely responsible 
for the decreased potency of C3. Despite making multiple intermolecular contacts in the 
PcTx1:cASIC1 crystal structure and our MD simulations, mutation of none of the other C-
terminal residues (V34A, P35A, K36A, and T37A) had any appreciable effect on the ability 
of PcTx1 to inhibit rASIC1a (Fig. 2C,D; Table 2). 
 
Assessment of rASIC1a residues predicted to interact with PcTx1. Our MD simulations 
identified a subset of cASIC1 residues that persistently interact with PcTx1 in solution. To 
experimentally test the MD predictions we constructed a panel of rASIC1a mutants (E235A, 
  
This article is protected by copyright. All rights reserved. 
Y316A, K354A and F350A; E236A, Y317A, K355A and F351A in cASIC1) and examined 
the effect of WT PcTx1 on each mutant. PcTx1 affects the pH of both activation and SSD of 
rASIC1a (Chen et al., 2005) and therefore we determined these parameters for each channel 
mutant (Supp. Fig. S3; Supp. Table S1) before examining whether they were altered in the 
presence of 30 nM WT PcTx1 (Fig. 3; Supp. Table S1). For the E235A, Y316A, and K354A 
channel mutants, PcTx1 induced a shift in the average pH50 of activation and SSD that was 
comparable to that of WT ASIC1a (Fig. 3). Thus, Glu235, Tyr316, and Lys354 are not 
critical for PcTx1 modulation of ASIC1a activity. In contrast, PcTx1 had no effect on the 
pH50 of activation or SSD for the F350A mutant (Fig. 3; Supp. Fig. S3), consistent with 
Phe350 being a key residue for interaction with PcTx1. The inhibitory efficiency of 30 nM 
PcTx1 was similar for all channel mutants (87–98%) when applied at 0.10–0.15 pH units 
higher than the pH50 of SSD with the exception of F350A for which there was no inhibition 
(Supp. Fig. S3). 
 
Discussion  
ASIC1a is a therapeutic target for diverse diseases including chronic pain and stroke. PcTx1 
is the most potent and selective inhibitor of ASIC1a reported to date, making it a valuable 
pharmacological tool and potential therapeutic lead. Crystal structures of the PcTx1:cASIC1 
complex (Baconguis and Gouaux, 2012; Dawson et al., 2012) revealed that the hydrophobic 
groove at the base of the HL of PcTx1 interacts with helix 5 of the cASIC1 thumb domain, 
while the side chains of Arg27 and Arg28 interact with negatively charged resides within the 
acidic pocket, thereby inducing and stabilising the open state of cASIC1. These structures 
provide an excellent foundation for understanding the PcTx1:ASIC1a interaction and 
developing therapeutically useful PcTx1 mimetics. However, rational design of small-
molecule mimetics requires an understanding of which residues at the protein-protein 
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interface make the largest contributions to the free energy of binding. Guided by the 
PcTx1:cASIC1 crystal structures, we combined MD simulations with mutagenesis of 
interface residues to determine which PcTx1 residues are critical for interaction with ASIC1a. 
Unrestrained MD simulations revealed that almost half of the interfacial contacts observed in 
PcTx1:cASIC1 crystal structures do not persist in solution. Dawson et al. (2012) reported 57 
interfacial contacts in the PcTx1:cASIC1 crystal structure contributed by 32 cASIC1 and 15 
PcTx1 residues (Dawson et al., 2012). Only 31 of these intermolecular interactions, involving 
20 channel and 12 peptide residues, persisted in a significant proportion of the configurations 
sampled during MD simulations. 
 
We used alanine-scanning mutagenesis to test predictions from the MD simulations and 
refine the list of critical PcTx1 contact residues. Five of the 13 residues mutated in this study 
(Lys6, Trp7, Arg28, Phe30, Val32) resulted in profound changes in the ability of PcTx1 to 
inhibit rASIC1a. The W7A mutant was almost completely inactive, while an R28A mutation 
reduced potency ~15-fold. In both cases, the substantial reduction in activity appears directly 
related to the loss of key sidechain-sidechain interactions. Both residues make extensive 
contacts with multiple channel residues in both the crystal structures and the MD simulations, 
and NMR data indicate that neither mutation substantially perturbs the structure of PcTx1. In 
a previous study we demonstrated a similarly profound loss of activity for W24A and R27A 
mutations, again without concomitant perturbation of the PcTx1 structure (Saez et al., 2011). 
Thus, we conclude that residues Trp24, Arg27 and Arg28 in the HL and Trp7 in loop 1 form 
the primary hot spot that mediates interaction of PcTx1 with rASIC1a (Fig. 4). This is 
consistent with the observation that Arg and Trp residues are highly enriched in protein-
protein interaction epitopes (Bogan and Thorn, 1998). 
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The effect of mutating Phe30 to Ala was unexpected, but similar to what we previously 
reported for a R26A mutation (Saez et al., 2011). Both mutations result in peptides that 
potentiate rather than inhibit rASIC1a. The R26A and F30A mutant peptides appear to bind 
rASIC1a and stabilise the open, rather than the desensitised, state. NMR studies on PcTx1 
revealed that the HL is flexible, and that Arg26 and Phe30 form a cation- interaction 
across the base of this loop (Saez et al., 2011). Dawson and colleagues also noted this 
interaction in the PcTx1:cASIC1 crystal structure (Dawson et al., 2012). PcTx1 inhibits rat 
and human ASIC1a by stabilising the desensitised state of the channel, and this effect appears 
to be primarily mediated by the side chains of Arg27 and Arg28 entering the acidic pocket 
and mimicking the action of protons. It is likely that Arg26 and Phe30 play a role in 
stabilising the HL of PcTx1 so that the side chains of Arg27 and Arg28 can be appropriately 
positioned to interact with carboxyl-carboxylate pairs in the acidic pocket. These residues 
also make interactions with helix 5 of the channel. Thus, we propose that the dramatic 
reversal of activity for the R26A and F30A mutants is due to loss of intermolecular channel 
interactions combined with altered intramolecular peptide interactions.  
 
The reduced potency of the K6A and V32A peptides is likely due to structural perturbations 
induced by the mutations. MD simulations suggest that Lys6 does not form any persistent 
close contacts with rASIC1a. NMR analysis indicated that the K6A mutation perturbs the 
conformation of the adjacent and functionally critical Trp7 (Supp. Fig. S1), and this is likely 
the cause of the reduction in activity. However, in the absence of a more conservative 
mutation, we cannot exclude the possibility that Lys6 engages in energetically important 
interactions with rASIC1a. 
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Mutation of PcTx1 residues predicted not to interact with rASICa (Glu31 and Lys36) had 
little to no effect on peptide activity. Mutation of Lys8 or Pro35 were also not deleterious 
even though these residues persistently interacted with channel residues Glu343 and Phe351, 
respectively, in MD simulations. Lys25 makes several interfacial contacts in one of the 
PcTx1:cASIC1 crystal structures (Dawson et al., 2012), but not the other (Baconguis and 
Gouaux, 2012), and no persistent interactions were observed in the MD simulations. 
Consistent with these observations, we previously showed that a K25A mutant is equipotent 
with native PcTx1 (Saez et al., 2011). Thus, Lys25 is not functionally important. Ser29 and 
Thr37 make multiple interfacial contacts in the PcTx1:cASIC1 crystal structures, and some of 
these interactions were noted in our MD simulations (Table 1), yet there was no deleterious 
effect of mutating either residue to alanine. These residues appear to be further examples of 
interfacial residues that make intimate intermolecular contacts but do not contribute 
significantly to the strength of the protein-protein interaction (Bogan and Thorn, 1998). 
 
Channel mutants were selected to assess the predictive power of the MD simulations rather 
than define the network of interacting residues on the channel. In agreement with the MD 
predictions, Asp349 (Asp350 in cASIC1) was previously shown to be important for PcTx1 
inhibition of ASIC1a (Salinas et al., 2006) and hence we did not mutate this residue. We 
selected Phe350 (Phe351 in cASIC1) as a positive control as it is known to be functionally 
important for the PcTx1:ASIC1a interaction (Sherwood et al., 2009), Glu235 as a negative 
control (no persistent contacts predicted by MD), and two intermediate cases (Tyr316 and 
Lys354). Experiments with an F350A mutant confirmed the importance of Phe350 for PcTx1 
activity (Sherwood et al., 2009). This data, combined with our analysis of PcTx1 mutants in 
this study and previous work (Saez et al., 2011), enables us to conclude that the 
intermolecular contacts observed in crystal structures of the PcTx1:cASIC1 complex between 
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Phe351 and PcTx1 residues Trp7 and Trp24 make crucial contributions to the strength of this 
bimolecular association.  
 
Our channel mutagenesis data revealed an absence of critical intermolecular interactions 
involving residues Glu236, Tyr317 and Lys355. The Glu236 data confirmed predictions from 
the MD simulations. However, mutation of Tyr317 or Lys355 had no substantial effect on the 
ability of PcTx1 to alter channel activation or SSD, despite persistent interactions with PcTx1 
in the MD simulations. This again highlights the point that just because two residues form 
close contacts at a protein-protein interface (e.g., based on structural data or MD simulations) 
does not necessarily mean that they contribute significantly to the free energy of binding as is 
commonly assumed. 
 
A potential caveat of this study is that we used cASIC1 in MD simulations (since structures 
are not available for other species) but employed rASIC1a for functional studies. The latter is 
more relevant from a medicinal chemistry perspective as rASIC1a and hASIC1a are 97% 
identical and PcTx1 inhibits both channels by stabilising the desensitised state. In contrast, 
PcTx1 induces activation of cASIC1, followed by slow decay to a steady-state current, thus 
stabilising an open state (Baconguis and Gouaux, 2012). Despite this, the conformational 
differences between the PcTx1 binding site in the desensitised and open states of cASIC1 
appears to be subtle (Baconguis and Gouaux, 2012; Gründer and Augustinowski, 2012). 
Thus, the cASIC1 structure used as a template for the MD studies should be a valid model. 
Indeed, the close agreement between our functional data on rASIC1a and MD simulations of 
the PcTx1:cASIC1 complex supports the use of MD data to guide functional studies.  
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Conclusions 
PcTx1 is a valuable lead molecule for development of therapeutically useful ASIC1a-
selective inhibitors, and consequently there is intense interest in understanding the molecular 
details of its interaction with ASIC1a. Although crystal structures of the PcTx1:cASIC1 
complex revealed an extensive network of >50 intermolecular contacts, we show here that 
only ~50% of these interactions are essential for PcTx1 inhibition of rASIC1a. The 
identification of a binding hot spot on PcTx1 comprising residues Trp7, Trp24, Arg26, 
Arg27, Arg28 and Phe30 provides a crucial platform for design of small-molecule PcTx1 
mimetics. 
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Table 1. Intermolecular interactions observed in the PcTx1:cASIC1 crystal structure 
(Baconguis and Gouaux, 2012; Dawson et al., 2012) and their persistence (% occurrence) in 
triplicate 30-ns MD simulations. 2.5 Å and 5 Å cut-offs were used to calculate fractional 
occurrence for hydrogen bond and other non-bonded interactions, respectively. Residues 
predicted by MD to form persistent interactions in solution are highlighted in bold. *, putative 
proton sensors; #, residues predicted to form hydrogen bonds. 
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Table 2. IC50/EC50 values for WT PcTx1 and each of the tested variants (point mutations and 
truncations). Potentiators are denoted by asterisks. Data are mean ± SEM. 
 
 
Peptide 
 
IC50 (nM)  Hill slope 
Fold-
change
1
 
 
WT 
 
0.35 ± 0.04  1.5  ± 0.04 — 
 
K6A 
 
34.2 ± 0.23  0.8  ± 0.26 97.7 
 
W7A 
 
   >1000       N/A >2857 
 
K8A 
 
0.59 ± 0.05  1.2 ± 0.15   1.7 
 
3–40, N2 
 
0.55 ± 0.06  1.4 ± 0.25   1.6 
 
R28A 
 
5.06 ± 0.03  1.2 ± 0.10 14.5 
 
S29A 
 
0.32 ± 0.02  1.6 ± 0.12   1.1 
 F30A  6.79 ± 0.30*  2.0 ± 0.48   N/A 
 
E31A 
 
0.76 ± 0.02  2.5 ± 0.30   2.2 
 
V32A 
 
6.27 ± 0.04  1.3 ± 0.14 17.9 
 
V34A 
 
0.49 ± 0.07  1.1 ± 0.18   1.4 
 
P35A 
 
0.13 ± 0.02  1.6 ± 0.12   2.7 
 
K36A 
 
0.19 ± 0.03  1.2 ± 0.09   1.8 
 
T37A 
 
0.25 ± 0.06  1.2 ± 0.17   1.4 
 
P38A 
 
1.36 ± 0.06  1.2 ± 0.18   3.9 
 
1–37, C3 
 
1.44 ± 0.04  1.2 ± 0.14   4.1 
1
Fold-change in activity relative to WT PcTx1. Italicised numbers 
indicate an increase in potency. Bold numbers indicate mutants that 
substantially diminish PcTx1 inhibition of rASIC1a. 
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Figure 1. Structure of PcTx1 and its complex with cASIC1. (A) Structure of PcTx1 (PDB 
2KNI) highlighting the 13 residues that were mutated to alanine in this study (side chains 
shown as sticks and labelled). Residues are grouped according to their location in the N-
terminal region (red oval), HL (blue oval), or C-terminal region (green oval). (B) Structure 
of the PcTx1:cASIC1 complex (PDB 3S3X). The three cASIC1 subunits are coloured purple, 
green and yellow, and the three PcTx1 molecules are shown as grey molecular surfaces. 
Views from the extracellular space (left) and parallel to the membrane (right) show each 
PcTx1 molecule binding into the acidic pocket between adjacent subunits. (C) Surface 
representation of PcTx1 binding between subunits viewed from beneath the acidic pocket. 
The basic residues of the HL (blue) protrude deep into the acidic pocket, and a hydrophobic 
patch (green) engages helix 5 of cASIC1. (D) Each box shows an expanded view of channel 
residues that were mutated in this study and their respective channel contacts predicted from 
the PcTx1:cASIC1 complex (PDB 3S3X; side chains shown as sticks and labelled). 
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Figure 2. Concentration-effect relationships for modulation of rASIC1a by PcTx1 and 
various analogues. Data are grouped according to the structural regions highlighted in Fig. 1, 
namely the (A) N-terminus, (B) HL, and (C-D) C-terminus. Data points are mean ± SEM 
(n = 4–8). The IC50 values and Hill coefficients obtained from non-linear fits of the Hill 
equation to the concentration-effect data are summarised in Table 2. 
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Figure 3. Effect of PcTx1 on pH-dependent properties of native and mutant rASIC1a. 
Average pH50 of (A) activation and (B) SSD in the absence and presence of 30 nM PcTx1. 
Data are mean ± SEM (n = 4–8). ns, not significant, and *, p < 0.005 (comparison of pH50 in 
the absence and presence of PcTx1). Residues are numbered according to the sequence of 
rASIC1a, with cASIC1 numbering in parentheses.  
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Figure 4. Key intermolecular interactions between PcTx1 and rASIC1a. (A) Flow 
diagram showing the process by which we identified key contacts for the PcTx1:rASIC1a 
interaction. (B) Surface representation of PcTx1 highlighting residues (blue and red) that 
make intermolecular contacts in crystal structures of the PcTx1:cASIC1 complex (Baconguis 
and Gouaux, 2012; Dawson et al., 2012). Alanine scanning mutagenesis revealed that only 
the residues shown in red are critical for interaction with rASIC1a. Shown in green are 
channel residues that, based on channel mutagenesis and MD simulations, appear to make the 
most energetically important interactions with each of the PcTx1a hot-spot residues (rASIC1a 
numbering, with "A" and "B" denoting subunit). The N- and C-termini are labelled. 
 
